Literature DB >> 23556137

Regarding "A Risperidone-induced Prolactinoma Resolved When A Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report".

Danielle Coppola1, Shanker Thiagarajah, Hong Qiu, David Hough.   

Abstract

Entities:  

Year:  2013        PMID： 23556137      PMCID： PMC3615507     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN： 2158-8333


× No keyword cloud information.
  23 in total

Review 1.  Perspectives on the use of data mining in pharmaco-vigilance.

Authors:  June Almenoff; Joseph M Tonning; A Lawrence Gould; Ana Szarfman; Manfred Hauben; Rita Ouellet-Hellstrom; Robert Ball; Ken Hornbuckle; Louisa Walsh; Chuen Yee; Susan T Sacks; Nancy Yuen; Vaishali Patadia; Michael Blum; Mike Johnston; Charles Gerrits; Harry Seifert; Karol Lacroix
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  The effect of aripiprazole and quinagolide, a dopamine agonist, in a patient with symptomatic pituitary prolactinoma and chronic psychosis.

Authors:  Rosalie Broekhof; Manon J Gosselink; Hanno Pijl; Erik J Giltay
Journal:  Gen Hosp Psychiatry       Date:  2011-08-26       Impact factor: 3.238

3.  Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.

Authors:  Ana Szarfman; Joseph M Tonning; Jonathan G Levine; P Murali Doraiswamy
Journal:  Pharmacotherapy       Date:  2006-06       Impact factor: 4.705

4.  Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects.

Authors:  Uriel Halbreich; Linda S Kahn
Journal:  J Psychiatr Pract       Date:  2003-09       Impact factor: 1.325

5.  Risperidone-induced galactorrhea associated with a prolactin elevation.

Authors:  A Popli; S Gupta; S R Rangwani
Journal:  Ann Clin Psychiatry       Date:  1998-03       Impact factor: 1.567

6.  A risperidone-induced prolactinoma resolved when a woman with schizoaffective disorder switched to ziprasidone: a case report.

Authors:  Gail T Arcari; Asante K Mendes; Robert B Sothern
Journal:  Innov Clin Neurosci       Date:  2012-09

7.  Atypical antipsychotics and pituitary neoplasms in the WHO database.

Authors:  P Murali Doraiswamy; Gisela Schott; Kristina Star; Ralph Edwards; Bruno Mueller-Oerlinghausen
Journal:  Psychopharmacol Bull       Date:  2007

Review 8.  The prevalence of pituitary adenomas: a systematic review.

Authors:  Shereen Ezzat; Sylvia L Asa; William T Couldwell; Charles E Barr; William E Dodge; Mary Lee Vance; Ian E McCutcheon
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

9.  Follow-up study of a pharmacovigilance signal: no evidence of increased risk with risperidone of pituitary tumor with mass effect.

Authors:  Madeline McCarren; Hong Qiu; Najat Ziyadeh; Rong Jiang; Yu Wang; Andrew T McAfee
Journal:  J Clin Psychopharmacol       Date:  2012-12       Impact factor: 3.153

10.  Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia.

Authors:  Hongyan Zhang; Huafang Li; Liang Shu; Niufan Gu; Gang Wang; Yongzhen Weng; Shiping Xie; Xinbao Zhang; Ting Li; Cui Ma; Wei Yu; Bruce Parsons; Manjula Schou
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-04       Impact factor: 2.570
View more
  1 in total

Review 1.  The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Authors:  J Peuskens; L Pani; J Detraux; M De Hert
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.